The Final Frontier - Online Remote Trading Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Final Frontier - Online Remote Trading

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Susan Saline who wrote (4242)	5/20/1998 4:13:00 PM
From: CountofMoneyCristo	Read Replies (1) of 12617

NYMXF - Nymox Pharmaceuticals - up 16.35% at 7 9/16, almost certain to issue press release on the heels of NEOT's meteoric, over 100% rise today. NEOT issued a release stating it had developed a drug that is 100% effective in restoring some memory to Alzheimer's patients. Alert traders will remember Nymox's stock shooting up 100% to 12 7/8 intraday in February when it issued a similar release. Nymox owns a patent on a potent test for Alzheimer's. Stock almost certain to soar on at least sympathy with NEOT, when the Street get around to realizing the effect on Nymox of NEOT's news. Nymox remains at the forefront of Alzheimer's research.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next